vs

Side-by-side financial comparison of Baxter International (BAX) and Cognizant (CTSH). Click either name above to swap in a different company.

Cognizant is the larger business by last-quarter revenue ($5.4B vs $2.7B, roughly 2.0× Baxter International). Cognizant runs the higher net margin — 12.2% vs -0.6%, a 12.8% gap on every dollar of revenue. On growth, Cognizant posted the faster year-over-year revenue change (5.8% vs 3.0%). Cognizant produced more free cash flow last quarter ($198.0M vs $76.0M). Over the past eight quarters, Cognizant's revenue compounded faster (5.6% CAGR vs -15.8%).

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.

Cognizant Technology Solutions Corporation is an American multinational information technology consulting and outsourcing company originally founded in India. It is headquartered in Teaneck, New Jersey, United States. Cognizant is part of the NASDAQ-100 and trades under CTSH. It was founded in Chennai, India, as an in-house technology unit of Dun & Bradstreet in 1994, and started serving external clients in 1996.

BAX vs CTSH — Head-to-Head

Bigger by revenue
CTSH
CTSH
2.0× larger
CTSH
$5.4B
$2.7B
BAX
Growing faster (revenue YoY)
CTSH
CTSH
+2.8% gap
CTSH
5.8%
3.0%
BAX
Higher net margin
CTSH
CTSH
12.8% more per $
CTSH
12.2%
-0.6%
BAX
More free cash flow
CTSH
CTSH
$122.0M more FCF
CTSH
$198.0M
$76.0M
BAX
Faster 2-yr revenue CAGR
CTSH
CTSH
Annualised
CTSH
5.6%
-15.8%
BAX

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BAX
BAX
CTSH
CTSH
Revenue
$2.7B
$5.4B
Net Profit
$-15.0M
$662.0M
Gross Margin
33.0%
Operating Margin
2.4%
15.6%
Net Margin
-0.6%
12.2%
Revenue YoY
3.0%
5.8%
Net Profit YoY
-0.2%
EPS (diluted)
$-0.03
$1.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAX
BAX
CTSH
CTSH
Q1 26
$2.7B
$5.4B
Q4 25
$3.0B
$5.3B
Q3 25
$2.8B
$5.4B
Q2 25
$2.8B
$5.2B
Q1 25
$2.6B
$5.1B
Q4 24
$533.0M
$5.1B
Q3 24
$2.7B
$5.0B
Q2 24
$3.8B
$4.8B
Net Profit
BAX
BAX
CTSH
CTSH
Q1 26
$-15.0M
$662.0M
Q4 25
$-1.1B
$648.0M
Q3 25
$-46.0M
$274.0M
Q2 25
$91.0M
$645.0M
Q1 25
$126.0M
$663.0M
Q4 24
$-512.0M
$546.0M
Q3 24
$140.0M
$582.0M
Q2 24
$-314.0M
$566.0M
Gross Margin
BAX
BAX
CTSH
CTSH
Q1 26
33.0%
Q4 25
19.4%
Q3 25
33.5%
Q2 25
35.3%
Q1 25
32.8%
Q4 24
25.0%
Q3 24
38.3%
Q2 24
37.5%
Operating Margin
BAX
BAX
CTSH
CTSH
Q1 26
2.4%
15.6%
Q4 25
-24.5%
16.0%
Q3 25
6.1%
16.0%
Q2 25
6.8%
15.6%
Q1 25
2.2%
16.7%
Q4 24
-25.5%
14.8%
Q3 24
5.7%
14.6%
Q2 24
-5.0%
14.6%
Net Margin
BAX
BAX
CTSH
CTSH
Q1 26
-0.6%
12.2%
Q4 25
-37.9%
12.2%
Q3 25
-1.6%
5.1%
Q2 25
3.2%
12.3%
Q1 25
4.8%
13.0%
Q4 24
-96.1%
10.7%
Q3 24
5.2%
11.5%
Q2 24
-8.2%
11.7%
EPS (diluted)
BAX
BAX
CTSH
CTSH
Q1 26
$-0.03
$1.39
Q4 25
$-2.21
$1.35
Q3 25
$-0.09
$0.56
Q2 25
$0.18
$1.31
Q1 25
$0.25
$1.34
Q4 24
$-0.99
$1.10
Q3 24
$0.27
$1.17
Q2 24
$-0.62
$1.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAX
BAX
CTSH
CTSH
Cash + ST InvestmentsLiquidity on hand
$1.5B
Total DebtLower is stronger
$568.0M
Stockholders' EquityBook value
$15.1B
Total Assets
$20.5B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAX
BAX
CTSH
CTSH
Q1 26
$1.5B
Q4 25
$2.0B
$1.9B
Q3 25
$1.7B
$2.4B
Q2 25
$1.7B
$1.8B
Q1 25
$2.3B
$2.0B
Q4 24
$1.8B
$2.2B
Q3 24
$1.4B
$2.0B
Q2 24
$2.1B
$2.2B
Total Debt
BAX
BAX
CTSH
CTSH
Q1 26
$568.0M
Q4 25
$9.5B
Q3 25
Q2 25
Q1 25
Q4 24
$10.4B
Q3 24
$10.4B
Q2 24
$10.4B
Stockholders' Equity
BAX
BAX
CTSH
CTSH
Q1 26
$15.1B
Q4 25
$6.1B
$15.0B
Q3 25
$7.2B
$14.9B
Q2 25
$7.3B
$15.3B
Q1 25
$7.1B
$14.9B
Q4 24
$7.0B
$14.4B
Q3 24
$7.9B
$14.5B
Q2 24
$7.6B
$13.9B
Total Assets
BAX
BAX
CTSH
CTSH
Q1 26
$20.5B
Q4 25
$20.1B
$20.7B
Q3 25
$21.1B
$20.1B
Q2 25
$21.0B
$20.2B
Q1 25
$21.3B
$20.0B
Q4 24
$25.8B
$20.0B
Q3 24
$26.7B
$20.2B
Q2 24
$26.3B
$18.6B
Debt / Equity
BAX
BAX
CTSH
CTSH
Q1 26
0.04×
Q4 25
1.55×
Q3 25
Q2 25
Q1 25
Q4 24
1.49×
Q3 24
1.33×
Q2 24
1.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAX
BAX
CTSH
CTSH
Operating Cash FlowLast quarter
$274.0M
Free Cash FlowOCF − Capex
$76.0M
$198.0M
FCF MarginFCF / Revenue
2.8%
3.7%
Capex IntensityCapex / Revenue
5.1%
Cash ConversionOCF / Net Profit
0.41×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAX
BAX
CTSH
CTSH
Q1 26
$274.0M
Q4 25
$584.0M
$858.0M
Q3 25
$237.0M
$1.2B
Q2 25
$217.0M
$398.0M
Q1 25
$-193.0M
$400.0M
Q4 24
$488.0M
$920.0M
Q3 24
$253.0M
$847.0M
Q2 24
$115.0M
$262.0M
Free Cash Flow
BAX
BAX
CTSH
CTSH
Q1 26
$76.0M
$198.0M
Q4 25
$781.0M
Q3 25
$1.2B
Q2 25
$331.0M
Q1 25
$323.0M
Q4 24
$837.0M
Q3 24
$791.0M
Q2 24
$183.0M
FCF Margin
BAX
BAX
CTSH
CTSH
Q1 26
2.8%
3.7%
Q4 25
14.6%
Q3 25
21.4%
Q2 25
6.3%
Q1 25
6.3%
Q4 24
16.5%
Q3 24
15.7%
Q2 24
3.8%
Capex Intensity
BAX
BAX
CTSH
CTSH
Q1 26
5.1%
Q4 25
1.4%
Q3 25
1.2%
Q2 25
1.3%
Q1 25
1.5%
Q4 24
1.6%
Q3 24
1.1%
Q2 24
1.6%
Cash Conversion
BAX
BAX
CTSH
CTSH
Q1 26
0.41×
Q4 25
1.32×
Q3 25
4.48×
Q2 25
2.38×
0.62×
Q1 25
-1.53×
0.60×
Q4 24
1.68×
Q3 24
1.81×
1.46×
Q2 24
0.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons